Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bankrate Inc (RATE): Hedge Funds Are Bearish and Insiders Are Bullish, What Should You Do?

Page 1 of 2

Bankrate Inc (NYSE:RATE) investors should pay attention to a decrease in activity from the world’s largest hedge funds recently. However, today Bankrate Inc (NYSE:RATE) has been increased at Stifel.

In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to watch the equity markets. A duo of the
that, historically, those who follow the best picks of the elite money managers can trounce the market by a significant margin (see just how much).most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown

Just as key, optimistic insider trading activity is another way to parse down the marketplace. Obviously, there are a number of stimuli for an executive to sell shares of his or her company, but only one, very clear reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the valuable potential of this tactic if piggybackers know what to do (learn more here).

Keeping this in mind, we’re going to take a peek at the key action surrounding Bankrate Inc (NYSE:RATE).

How are hedge funds trading Bankrate Inc (NYSE:RATE)?

In preparation for this year, a total of 5 of the hedge funds we track were bullish in this stock, a change of -44% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings meaningfully.


Of the funds we track, Citadel Investment Group, managed by Ken Griffin, holds the biggest position in Bankrate Inc (NYSE:RATE). Citadel Investment Group has a $43.4 million position in the stock, comprising 0.1% of its 13F portfolio. The second largest stake is held by Royce & Associates, managed by Chuck Royce, which held a $21.4 million position; 0.1% of its 13F portfolio is allocated to the company. Other peers that are bullish include James A. Noonan’s Pivot Point Capital, Jim Simons’s Renaissance Technologies and D. E. Shaw’s D E Shaw.

Because Bankrate Inc (NYSE:RATE) has witnessed bearish sentiment from the smart money, we can see that there were a few funds who sold off their full holdings last quarter. Interestingly, Lee Ainslie’s Maverick Capital sold off the largest stake of all the hedgies we watch, totaling close to $9.4 million in stock.. Israel Englander’s fund, Millennium Management, also dumped its stock, about $6.1 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest fell by 4 funds last quarter.

What do corporate executives and insiders think about Bankrate Inc (NYSE:RATE)?

Bullish insider trading is particularly usable when the company in question has experienced transactions within the past half-year. Over the last six-month time frame, Bankrate Inc (NYSE:RATE) has experienced 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Bankrate Inc (NYSE:RATE). These stocks are InterXion Holding NV (NYSE:INXN), Shutterfly, Inc. (NASDAQ:SFLY), Kayak Software Corp (NASDAQ:KYAK), Yelp Inc (NYSE:YELP), and OpenTable Inc (NASDAQ:OPEN). All of these stocks are in the internet information providers industry and their market caps resemble RATE’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!